Ligand profile
ZINC9659886
Virtual-screening candidate from ZINC.
Bound to: VK055_4666 — guaA GMP synthetase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC9659886- UniProt (similar protein)
Q8IJR9- Tanimoto
- 0.532
- Target protein
- VK055_4666
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 206.8
- −1 ≤ LogP ≤ 5 -2.74
- MW ≤ 500 Da 363.2
- LogP ≤ 5 -2.74
- H-bond donors ≤ 5 7
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 206.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
N=c1[nH]c(=O)c2ncn([C@@H]3O[C@@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c2[nH]1N=c1[nH]c(=O)c2ncn([C@@H]3O[C@@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c2[nH]1
InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5+,6+,9+/m0/s1InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5+,6+,9+/m0/s1
RQFCJASXJCIDSX-HAVMAKPUSA-NRQFCJASXJCIDSX-HAVMAKPUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- XMP
- Homolog
- Q8IJR9
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC9659886 →
- ZINC ZINC20 ZINC9659886 →
- UniProt UniProt Q8IJR9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC9659886”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4666.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).